Company Filing History:
Years Active: 2015
Title: Innovations of Santimukal Santra in Nanotechnology
Introduction
Santimukal Santra is an accomplished inventor based in Orlando, FL. He has made significant contributions to the field of nanotechnology, particularly in the synthesis of specialized polymers. His work focuses on developing materials that have both therapeutic and diagnostic applications.
Latest Patents
Santimukal Santra holds a patent for the "Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof." This innovative method involves creating a hyperbranched amphiphilic polyester compound through a detailed process that includes drying a mixture of 2-(4-hydroxybutyl)-malonic acid and p-toluene sulphonic acid under vacuum. The polymerization occurs under inert gas, leading to the formation of nanoparticles that can coencapsulate fluorescent dyes and therapeutic drugs. This dual functionality makes these nanoparticles valuable for both therapeutic treatments and diagnostic methods.
Career Highlights
Santimukal Santra is affiliated with the University of Central Florida Research Foundation, Inc. His work has been instrumental in advancing the understanding and application of nanomaterials in medicine. He has a strong focus on developing innovative solutions that bridge the gap between therapy and diagnostics.
Collaborations
Santimukal has collaborated with J Manuel Perez, contributing to the advancement of research in their field. Their partnership has led to significant developments in the synthesis and application of nanotechnology.
Conclusion
Santimukal Santra's innovative work in the synthesis of theranostic nanoparticles showcases his expertise and commitment to advancing nanotechnology. His contributions are paving the way for new therapeutic and diagnostic solutions in medicine.